Insights

This study introduces a new non-contrast cardiac MRI method for assessing myocardial infarction damage. The technique offers excellent reproducibility and map quality, paving the way for safer patient assessments.

Area of Science:

  • Cardiovascular Magnetic Resonance Imaging
  • Biomarker Development
  • Medical Physics

Background:

  • Ischemic heart disease (IHD) is a leading cause of death, with myocardial infarction (MI) accounting for a third of cases.
  • Cardiac MRI, particularly Late Gadolinium Enhancement (LGE), assesses MI damage but gadolinium contrast agents have limitations.
  • Spin-lock (SL) dispersion is a promising non-contrast alternative, but current methods face challenges at 3T, including Specific Absorption Rate (SAR) limitations and artifacts.

Purpose of the Study:

  • To develop and validate a novel, single breath-hold, simultaneous TRAFF2 and T2 mapping sequence for spin-lock (SL) dispersion mapping at 3T.
  • To overcome SAR limitations and off-resonance artifacts associated with traditional SL preparations.
  • To provide a non-contrast MRI method for assessing myocardial viability and fibrosis in patients with MI.

Main Methods:

  • Development of a simultaneous TRAFF2 and T2 mapping sequence for 3T MRI.
  • Acquisition and analysis of data in phantom experiments to assess reproducibility and map quality.
  • Comparison of results with reference methods for TRAFF2, T2, and SL dispersion values.
  • In vivo imaging to evaluate clinical applicability and artifact levels.

Main Results:

  • The proposed sequence demonstrated excellent reproducibility in phantom studies (coefficient of variations < 10%).
  • Myocardial TRAFF2, T2, and SL dispersion values obtained were comparable to reference methods.
  • High-quality T2, TRAFF2, and SL dispersion maps were achieved in phantoms and in vivo, free from major artifacts.

Conclusions:

  • The developed single breath-hold sequence enables accurate and reproducible SL dispersion mapping at 3T.
  • This non-contrast approach offers a promising alternative to LGE for assessing MI-related myocardial damage and fibrosis.
  • The technique has significant potential for clinical application in MI assessment, improving patient safety and accessibility.